BRITTANY PTACHICK: Open Payments
NPI 1053866707 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 33 payments from 15 companies in 2025. Trend: 2023 $718 · 2024 $1,135 · 2025 $791
Food & beverage: $702Education: $89
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $230 |
| ABBVIE INC. | 8 | $166 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $48 |
| Galderma Laboratories, L.P. | 2 | $37 |
| BioCryst US Sales Co., LLC | 1 | $35 |
| Genentech USA, Inc. | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: DUPIXENT, QULIPTA, XOLAIR, NUCALA, NEFFY, ORLADEYO, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
